The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ANIKA THERAPEUTICS INC | COM | 035255108 | 6,178 | 114,600 | SH | SOLE | 114,600 | 0 | 0 | ||
ANTHEM INC | COM | 036752103 | 2,768 | 12,300 | SH | SOLE | 12,300 | 0 | 0 | ||
BIOGEN INC | COM | 09062X103 | 2,676 | 8,400 | SH | SOLE | 8,400 | 0 | 0 | ||
BRISTOL MYERS SQUIBB CO | COM | 110122108 | 2,660 | 43,400 | SH | SOLE | 43,400 | 0 | 0 | ||
CARDINAL HEALTH INC | COM | 14149Y108 | 2,794 | 45,600 | SH | SOLE | 45,600 | 0 | 0 | ||
CHARLES RIV LABS INTL INC | COM | 159864107 | 2,924 | 26,712 | SH | SOLE | 26,712 | 0 | 0 | ||
CIGNA CORPORATION | COM | 125509109 | 2,721 | 13,400 | SH | SOLE | 13,400 | 0 | 0 | ||
GILEAD SCIENCES INC | COM | 375558103 | 2,586 | 36,100 | SH | SOLE | 36,100 | 0 | 0 | ||
LABORATORY CORP AMER HLDGS | COM NEW | 50540R409 | 2,839 | 17,800 | SH | SOLE | 17,800 | 0 | 0 | ||
LIGAND PHARMACEUTICALS INC | COM NEW | 53220K504 | 2,766 | 20,200 | SH | SOLE | 20,200 | 0 | 0 | ||
LILLY ELI & CO | COM | 532457108 | 2,703 | 32,000 | SH | SOLE | 32,000 | 0 | 0 | ||
MCKESSON CORP | COM | 58155Q103 | 2,776 | 17,800 | SH | SOLE | 17,800 | 0 | 0 | ||
MEDTRONIC PLC | SHS | G5960L103 | 2,762 | 34,200 | SH | SOLE | 34,200 | 0 | 0 | ||
PFIZER INC | COM | 717081103 | 2,720 | 75,100 | SH | SOLE | 75,100 | 0 | 0 | ||
QUEST DIAGNOSTICS INC | COM | 74834L100 | 2,807 | 28,500 | SH | SOLE | 28,500 | 0 | 0 | ||
WATERS CORP | COM | 941848103 | 2,705 | 14,000 | SH | SOLE | 14,000 | 0 | 0 |